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The epidermis forms a vital barrier composed of stratified keratinocytes and their differentiated products. One of these products,
keratin K10, is critical to epidermal integrity, because mutations in k10 lead to abnormal blistering. For the normal expression
of k10, differentiation-associated transcription factors C/EBPa, C/EBPb, and AP-2 are well positioned to play an important role.
ere, regulation of the k10 gene is examined in keratinocytes in the skin of normal mice and in transgenic mice carrying targeted
eletions of c/ebpb and ap-2a. In cultured cells, C/EBPa and C/EBPb are each capable of activating the k10 promoter via three
inding sites, identified by site-directed mutagenesis. In a given epidermal cell in vivo, however, the selection of C/EBPa versus
/EBPb for k10 regulation is determined via a third transcription factor, AP-2. This novel regulatory scheme involves: (1) unique
gradients of expression for each transcription factor, i.e., C/EBPb and AP-2 most abundant in the lower epidermis, C/EBPa in the
pper; (2) C/EBP-binding sites in the ap-2a gene promoter, through which C/EBPb stimulates ap-2a; and (3) AP-2 binding sites
in the c/ebpa promoter, through which AP-2 represses c/ebpa. Promoter-analysis and gene-expression data presented herein
upport a regulatory model in which C/EBPb activates and maintains AP-2 expression in basal keratinocytes, whereas AP-2
represses C/EBPa in those cells. In response to differentiation signals, loss of AP-2 expression leads to derepression of the c/ebpa












The skin is the largest organ in the body and provides a
vital barrier against fluid loss, chemical and infectious
agents, and UV light (Goldsmith, 1991). This protection is
provided by the epidermis, a stratified tissue composed of
progenitor cells in the basal layer and differentiated kera-
tinocytes in the suprabasal layers. The keratinocytes pro-
duce differentiation-specific proteins, including keratins,
involucrin, and loricrin (Eckert et al., 1997; Fuchs, 1990),
that ultimately become cross-linked during cornification, a
specialized form of apoptosis (Haake and Polakowska,
1993). Keratin K10 is expressed early during the differentia-
tion of keratinocytes and is essential for epidermal integ-
rity. Loss of normal k10 expression, through dominant-
164egative mutations in the heritable disorder epidermolytic
yperkeratosis, leads to epidermal disruption and blistering
Cheng et al., 1992; Rothnagel et al., 1992; Syder et al., 1994).
Mechanisms that control k10 expression are poorly un-
erstood. In the basal epidermal layer, k10 transcription is
uppressed and becomes activated upon entering the supra-
asal compartment (Roop et al., 1988). We are interested in
actors that regulate k10 expression. Because of its abun-
ance in the skin and restriction to the basal layer, we
onsidered the transcription factor AP-21 as one such factor
Byrne et al., 1994; Leask et al., 1991; Mitchell et al., 1991).
P-2 (also called AP-2a) is a member of a family that now1 Abbreviations used: C/EBP, CCAAT/enhancer binding protein;
AP-2, activator protein 2.
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165C/EBP and AP-2 Transcription Factor Network in Skinincludes AP-2b (Moser et al., 1995) and AP-2g (Oulad-
bdelghani et al., 1996); these proteins dimerize via a
elix-span-helix domain (Williams and Tjian, 1991) and
ind to the consensus sequence 59-GCCN3(4)GGC-39 in
NA (Mitchell et al., 1987). One or more proteins of the
P-2 family are important for the transcriptional regulation
f K14, a keratin expressed specifically in the basal epider-
al layer (Byrne et al., 1994).
Transcription factors of the C/EBP (CCAAT-enhancer
inding protein) family are also candidates for regulation of
10 transcription, because of their links to cellular differ-
ntiation (see below). C/EBPs are members of the leucine
ipper or “bZIP” family of transcription factors (Haas et al.,
995; Lamb and McKnight, 1991; Vinson et al., 1993),
ecognized early on for their involvement in cellular differ-
ntiation (McKnight, 1992). C/EBPs bind to degenerate
ucleotide sequence sites consisting of a consensus motif
A/GTTNNGC/TAAC/T (McKnight, 1992; Osada et al., 1996;
yden and Beemon, 1989; Ubeda et al., 1996); the pseudo-
alindromic bases (in italic) separated by four intervening
asepairs are invariable. A role for C/EBPs in cellular
ifferentiation has been established in adipocytes in which
ifferentiation is accompanied by unique temporal changes
n the levels of individual C/EBP members. Upregulation of
/EBPd and C/EBPb precedes expression of C/EBPa (Cao et
l., 1991; MacDougald and Lane, 1995; Yeh et al., 1995) and
f fat-specific genes (Friedman et al., 1989). Direct trans-
enic overexpression of C/EBPa (Freytag et al., 1994; Lin
nd Lane, 1994) or of C/EBPb (Yeh et al., 1995) accelerates
the differentiation of adipoblasts into adipocytes. These
observations suggest that expression of C/EBPb initially,
and C/EBPa at a later time, is a prerequisite for correct
xpression of the differentiation-specific genes.
Both C/EBPs and AP-2 display broad regulatory potential,
hrough the existence of multiple isoforms and autoregula-
ory loops. Dominant-negative isoforms of the C/EBPs
Descombes and Schibler, 1991; Lin et al., 1993; Ossipow et
al., 1993; Ron and Habener, 1992) or of AP-2 (Meier et al.,
1995) heterodimerize with other isoforms in the same class,
thus counteracting stimulatory effects. Autoregulation oc-
curs because the promoters for c/ebpa (Christy et al., 1991;
in et al., 1993), c/ebpb (Chang et al., 1990), and chop
(Fawcett et al., 1996; Sylvester et al., 1994) each contain
C/EBP-binding motifs that should be available for interac-
tions with both stimulatory and inhibitory C/EBP isoforms.
The notion of counterregulation among C/EBP family
genes, at the level of their individual promoters, was
recently extended by the observation of a system of cross-
talk between AP-2 and C/EBPs. CUP (C/EBPa undifferenti-
ted protein), a repressor of the C/EBPa promoter in pre-
adipocytes (Tang et al., 1997) which disappears as the cells
differentiate, is identical to AP-2 (Jiang et al., 1998).
C/EBPs have only recently been examined in the epider-
is (Maytin and Habener, 1998; Oh and Smart, 1998; Swart
t al., 1997). Earlier, we examined the expression of C/EBPs
n keratinocytes of the mouse and found that C/EBPb and
CHOP are expressed early, whereas C/EBPa is expressed
f
e
Copyright © 1999 by Academic Press. All rightlate during keratinocyte differentiation in vitro (Maytin and
Habener, 1998). C/EBPs are expressed in the skin in a
spatially organized manner that corresponds to the timing
of expression seen in cultured keratinocytes in vitro, i.e.,
C/EBPb and CHOP appear first in the lower undifferenti-
ted epidermis, followed later by C/EBPa in the upper
differentiated epidermis (Maytin and Habener, 1998). These
findings imply that C/EBPs may exert functions in epider-
mal differentiation.
Here, the functions of C/EBPs in skin development and
differentiation are examined more directly, emphasizing
their role in k10 regulation. A segment of the mouse k10
promoter was used for transactivation and mutagenesis
work in BALB/MK cells, a cell culture model of epidermal
differentiation. Changes in k10 expression were found to be
mediated via three C/EBP binding sites within the k10
promoter. Gene expression was examined in mice with a
targeted disruption of the c/ebpb gene (cebpb null). The
/ebpb null mice displayed a marked ectopic increase of
/EBPa and K10 expression in the basal epidermis. Based
on the known suppression of C/EBPa by AP-2 in adipocytes,
we hypothesized that increase of C/EBPa in the skin of
c/ebpb null mice might represent a release of the c/ebpa
gene from transcriptional repression and that the repressor
might be AP-2. Experiments in c/ebpb null mice showing
loss of AP-2 expression, and other experiments showing
that ap-2a null mice reproduce the skin phenotype of the
/ebpb null mice, support this hypothesis. Overall, the data
uggest a model of regulation in which C/EBPb activates or
maintains AP-2 expression, and AP-2 represses C/EBPa, in
undifferentiated keratinocytes. In response to differentia-
tion signals, a loss of AP-2 expression leads to derepression
of the C/EBPa promoter and contributes to activation of the
k10 gene. This novel system of crosstalk between C/EBPs
and AP-2 appears to contribute to the regulation of the
differentiation-specific gene k10 in the mammalian epider-
mis.
MATERIALS AND METHODS
Preparation of Skin Specimens from Mice
Nullizygous for c/ebpb and ap-2
Mice in which the bZIP region of the c/ebpb gene has been
deleted (Screpanti et al., 1995) were a gift from Dr. Valeria Poli.
These mice were backcrossed into an FVB/n background (Charles
River, Wilmington, MA), and the line was maintained as heterozy-
gous breeding pairs. ap-2a null mice, lacking a genomic segment
ontaining exon 5 of the ap-2a gene (Schorle et al., 1996), were also
sed. Because ap-2a null mice die perinatally, embryos from
matings of heterozygotes were harvested shortly before birth (e17.5
to e18.5). The genotype of each individual was determined by PCR
of tail DNA or yolk-sack DNA, for c/ebpb or ap-2a, respectively.
For histological studies with c/ebpb knockout mice, pieces of
skin from pairs of adult mice (c/ebpb 1/2 and c/ebpb 2/2,
atched for age and sex) were embedded side by side in OCT
reezing compound (Miles, Inc., Elkhart, IN) along with some
xtraneous tissue as an orientation marker. Frozen blocks were









































166 Maytin et al.then cut into 5-mm sections and stained as described under “Im-
munocytochemistry.” For ap-2a studies, wild-type or ap-2a 1/2
mbryos were embedded side by side with ap-2a homozygous null
embryos from the same litter. In this approach, paired tissue
samples were exposed to identical conditions at every step in the
processing for immunochemical analyses.
Cell Culture and Differentiation Protocol
BALB/MK cells (Weissman and Aaronson, 1983) were grown in
EMEM containing low calcium (0.07 mM; Biofluids, Inc., Rock-
ville, MD) to which 5 ng/ml EGF (Collaborative Research, Bedford,
MA) and 10% Chelex-treated serum (Marcelo et al., 1978) were
added. For calcium step-up experiments, EMEM supplemented
with calcium to 0.12 mM (Yuspa and Dlugosz, 1991) was added to
confluent cells, and this “high-calcium” medium was changed
daily for the duration of the experiment to minimize effects from
nutrient depletion.
Cell Transfection and Luciferase Assays
Eukaryotic expression plasmids containing the C/EBPa, C/EBPb,
nd CHOP coding sequences in pCDNA1 (InVitrogen) have been
escribed (Ron and Habener, 1992). These plasmids, along with
uciferase reporter constructs (see “Cloning,” below), were trans-
ected into subconfluent BALB/MK cells using a standard calcium-
hosphate precipitate (Ausbel et al., 1992) or using Lipofectamine
Gibco BRL, 6 ml per 60-mm dish, 5 h exposure). At 48 h after
ransfection, cells were rinsed with cold PBS, lysed in glycyl-
lycine buffer with 0.1% Triton X, and assayed for luciferase
ctivity in an AutoLumat LB 953 luminometer (Berthold Analyti-
al Instruments, Nashua, NH) as described (Brasier et al., 1989).
Cloning and Analysis of the Mouse k10
and ap-2a Promoters
A fragment of the mouse K10 gene promoter was obtained by
utilizing a highly conserved sequence of nucleotides at 2245 bp,
pparent on cross-species examination of bovine and human K10
enes. A 19-base oligonucleotide corresponding to this conserved
egion was used as the 59 primer for PCR amplification of mouse
enomic DNA from NIH 3T3 cells; the matched 39 primer corre-
ponded to the known coding sequence of k10 at 1185 bp. The
esulting 430-bp PCR product, containing 245 bp of promoter and
85 bp of k10 coding sequence, was ligated into plasmid pCRII (TA
cloning kit; InVitrogen, San Diego, CA) to create the construct
K10-pCRII. To obtain a fragment containing only the promoter,
two PCR primers were designed to anneal at positions 2245 bp and
11 bp adding extra bases to create restriction sites as follows:
59-KpnI primer, CGG GGG TAC CCA TTT TCA ATT TC; 39-BglII
primer, GAA GAT CTG GTG GTG TAG TGT AGC CC. Using
these two primers and the K10-pCRII construct as templates, an
;250-bp fragment was obtained by PCR and cloned into the
KpnI/BglII sites of the pGL2-Basic vector (Promega, Madison, WI)
and thence into the SmaI–HindIII site of SKLuc to place the
wild-type k10 promoter directly upstream of the luciferase gene.
This new construct was named K10-Luc. The orientation and
integrity of all inserts were confirmed by DNA sequencing. To
produce the mutants described in Figs. 4C–4E, site-directed mu-
tagenesis was performed using the QuickChange kit from Strat-
agene. The sequence of mutations introduced at Sites A, B, and C
in the k10 promoter was identical to that of oligonucleotides Mut
A, Mut B, and Mut C (see Fig. 3C and “EMSA,” below).
e
a
Copyright © 1999 by Academic Press. All rightA region of the mouse ap-2a gene containing C/EBP-binding
otifs at 2710 and 2760 bp relative to the ATG codon in exon 1a
GenBank No. U17289) was synthesized as an 87-bp double-
tranded oligonucleotide with NotI and BamHI ends, then ligated
nto an SKLuc-based reporter containing a minimal promoter (11
o 286 bp of k10). This construct was named pWtAP2Luc. A
imilar construct, pMutAP2Luc, harbored mutations in both
/EBP-binding motifs (see Fig. 6 for sequence).
DNase I Footprint Analysis of the k10 Promoter
To create a probe suitable for analysis of site-specific binding of
proteins to DNA, the sense and antisense strands of the dsDNA
probe were individually labeled using [g-32P]ATP and T4 polynucle-
tide kinase to end-label the plasmid K10-pCRII that had been
leaved at a restriction site adjacent to the 59 end of the K10 insert.
ubsequently, the insert was released by restriction enzyme cleav-
ge at the unlabeled end. A truncated form of C/EBPb called
/EBPb-LIP, translated from an internal methionine and contain-
ing the bZIP binding domain (Poli et al., 1990), was used for
footprinting. The C/EBPb-LIP protein was produced as a histidine-
tagged fusion protein in pRSET-A (InVitrogen). After transforma-
tion of Escherichia coli strain BL21(DE3)pLysS and induction with
IPTG (Studier et al., 1990), cells were lysed and the supernatant
was applied over a nickel–NTA resin column (Qiagen, Inc., Chats-
worth, CA) and the protein eluted in a pH step gradient according
to instructions from the manufacturer. The DNase I protection
assay was performed by incubating the His-tagged C/EBPb with
50,000 cpm of 32P-labeled K10 probe at 4°C for 1 h prior to digestion
with DNase I, essentially as described (Galas and Schmidt, 1978).
Electrophoretic Mobility Shift Assays (EMSA)
Double-stranded DNA probes for EMSA experiments were pro-
duced by designing matched sense and antisense oligonucleotides
that produced BamHI/BglII 4-bp overhangs that could be filled in
with E. coli polymerase Klenow fragment and [32P]dATP. Oligonu-
leotides were synthesized in the MGH Biopolymer Facility and
urified by electrophoresis on urea-acrylamide gels. Probe se-
uences are given below. Sense strands are shown, with uppercase
etters denoting keratin K10 sequences and lowercase letters unre-
ated sequences, as they would appear after the Klenow fill-in
eaction. For Fig. 3C, wild-type probes (26 bp): Site A, gatcc TAA
TT ATG CAA TCA Tagatc; Site B, gatcc GTT ATT ACT GAA
AT Aagatc; Site C, gatcc AAA ACC ATG CAA GTA Aagatc. For
ig. 3C, mutant probes (26 bp) were identical to the wild-type
robes except for the basepair substitutions underlined, as follows:
ut A, gatcc TAA TTT ATG ATA TCA Tagatc; Mut B, gatcc GTG
ATC ACT GAA GAT Aagatc; Mut C, gatcc AAA AGG ATG CCC
GTA Aagatc. (For Fig. 4C, the same mutant bases underlined above
in Mut A, Mut B, or Mut C were introduced into the wild-type K10
promoter in various combinations by site-directed mutagenesis.) In
Fig. 3C and 3D, the “Standard” probe was a high-affinity C/EBP site
from the angiotensinogen gene, also known as M6 (Brasier et al.,
1990): gatc CAC AGT TGT GAT TTC ACA ACC TGA CCA
Gagatc. For Fig. 3D, the K10 probe was 44 bp, consisting of native
k10 sequence encompassing Sites A and B: attaCT GAA GAT AAT
TTA TGC AAT CAT AAG CCA AAG ATG Ctatg.
Gel-shift assays (EMSA) were performed as described (Vallejo et
al., 1992). Briefly, 20-ml reaction mixtures containing 1 ml of cell
xtract, 4 ml of albumin (10 mg/ml), 1 ml of poly(dIdC) (1 mg/ml),
nd 1 ml of 32P-labeled dsDNA probe (20,000 cpm) were prepared at
























167C/EBP and AP-2 Transcription Factor Network in Skina 50 mM final salt concentration and allowed to equilibrate for 20
min at 25°C. Complexes were separated on 5% Tris/borate acryl-
amide gels, and the dried gel was exposed to Kodak X-Omat AR
film overnight.
Immunocytochemistry
Mouse skin was frozen in OCT compound (Miles, Inc.), cut into
5-mm sections, and permeabilized in methanol prior to staining. For
the immunostaining of cells, BALB/MK cells were grown in four-
well plastic chamber slides (Nunc, Inc., Naperville, IL), fixed 5 min
in 1% paraformaldehyde, and permeabilized in methanol followed
by 0.1% Triton X-100 to promote access to nuclei (Collier and
Schlesinger, 1986). For paraffin-embedded skin, 5-mm sections were
deparaffinized by successive immersion in xylene, graded alcohols,
and saline. All specimens were blocked in 3% normal donkey
serum, incubated 12–18 h with primary antisera at 4°C, rinsed in
saline, and incubated 4 h at room temperature with the secondary
antibody. Slides were mounted in fluorescence mounting medium
(Kirkegaard & Perry Laboratories, Gaithersburg, MD) and viewed
under a Nikon Optiphot-2 microscope with epifluorescence attach-
ments. For most experiments, rabbit polyclonal antisera were used
as follows (dilution, commercial source): C/EBPa, C/EBPb,
gadd153/CHOP (1:50; Santa Cruz Biotechnology, Santa Cruz, CA),
AP-2 (1:500, Santa Cruz, sc-184), and keratin K10 and keratin K14
(1:500 and 1:2000, Berkeley Antibody Co., Berkeley, CA). Goat
polyclonal antisera against AP-2a (1:100, Santa Cruz, sc-6312) or a
ouse monoclonal antibody against keratin K10 (1:10, Sigma clone
.6) were used in Fig. 1 only. The secondary antibody for most
xperiments was Cy3-conjugated donkey anti-rabbit IgG (1:1500).
or double staining, Cy2-conjugated donkey anti-goat or anti-
ouse IgG were used (Jackson ImmunoResearch, West Grove, PA).
ntiserum sc-184 against AP-2 protein is not entirely specific for
P-2a. On Western blots loaded with roughly equimolar amounts
of recombinant, 35S-labeled AP-2a, AP-2b, or AP-2.2 (AP-2g), the
c-184 antibody recognizes all three proteins, although its affinity
or AP-2a is severalfold higher than for AP-2b or AP-2g (P. J.
Mitchell, data not shown).
Images were captured with a digital CCD camera (Optronics
Model TEC-470 camera) attached to a Macintosh 7100 PowerPC
computer with RasterOps framegrabber, running IPLab Spectrum
software (Signal Analytics Corp., Vienna, VA). Integration of signal
intensities, background subtraction, and normalization were per-
formed as described (Maytin and Habener, 1998).
Of particular note, the immunofluorescent staining patterns
obtained with C/EBP-specific antisera used here were previously
shown to accurately reflect the relative distribution of each C/EBP
protein within cells, both for keratinocytes in vitro and for the
epidermis in vivo, using Western blotting techniques (Maytin and
Habener, 1998).
RT-PCR and Southern Analysis
Equal amounts of total RNA (5 mg), prepared from BALB/MK
cells or from newborn mouse skin (guanidinium/phenol reagent,
TelTest “B”, Inc., Friendswood, TX) were reverse-transcribed using
1 ml oligo(dT) primers and the Superscript II kit (Gibco BRL),
ollowing the manufacturer’s instructions. As a negative control,
everse transcriptase was omitted from the reaction (data not
hown). Aliquots of cDNA were then analyzed by PCR, using
rimers to amplify a 220-bp region at the 39 end of the K10 mRNA.
his region corresponded to a K10 cDNA insert in pGEM-3 (gift
Copyright © 1999 by Academic Press. All rightrom Dr. Dennis Roop, Baylor College of Medicine, Houston, TX)
hat could be employed as a positive control for PCR. As a control,
ach cDNA sample was amplified using primers to mouse b-actin
Clontech, Palo Alto, CA). Southern blots were probed, after
ransfer of RT-PCR products to nitrocellulose membranes, using a
ixture of 32P-end-labeled oligonucleotides complementary to the
nternal region of the amplified K10 product.
Western Analysis
Western immunoblotting was performed using polyclonal K10
antisera at a 1:5000 dilution (gift from Dr. Stuart Yuspa, NCI,
Bethesda; also available from Berkeley Antibody Co.) as previously
described (Maytin and Habener, 1998). Films were quantified with
a 2-D laser scanning densitometer (Molecular Dynamics, Sunny-
vale, CA).
RESULTS
AP-2, C/EBPs, and Keratin K10 Are Differentially
Expressed in Stratifying Epidermis
The epidermis consists of morphologically distinct cell
layers, notable for their unique patterns of expression of
K10 and of the transcription factors AP-2, C/EBPa, and
C/EBPb (Fig. 1). Architecturally, a single proliferative layer
of basal cells is surmounted by differentiating suprabasal
cells, which eventually undergo apoptosis and become
cornified squames (see Fig. 1A and diagram). AP-2 is highly
expressed in the basal layer (Fig. 1B), with most of the
immunofluorescent signal coming from AP-2a (Mitchell et
l., 1991; and see Fig. 1E9) although some contribution from
P-2b and AP-2g cannot be excluded (see Materials and
Methods). In contrast, K10 appears only in the suprabasal
layers (Fig. 1C). C/EBPa is found in the upper suprabasal
layers (Fig. 1D), whereas C/EBPb is found in low amounts in
the basal layer and increases at the transition zone between
basal and suprabasal layers (Fig. 1E). C/EBPb and AP-2 are
both expressed in the basal layer, but levels of these two
factors change in a reciprocal manner; i.e., as cells migrate
upward into the cornified epithelium, C/EBPb increases
and AP-2 decreases (Figs. 1E and 1E9).
Immunocolocalization studies can establish putative re-
lationships between the expression of transcription factors
and potential target genes such as k10. Thus, AP-2 colocal-
izes with C/EBPb in the basal layer (Figs. 1E and 1E9), where
K10 expression is absent. At the basal/suprabasal boundary,
K10 expression begins; cells expressing K10 display an
increase in C/EBPb relative to the basal layer (Figs. 1F, 1F9,
and 1F0). In the high suprabasal (granular) layers, where
expression of C/EBPb begins to decline, K10 expression
colocalizes with C/EBPa (cf. Figs. 1D and 1F).
The Promoter of the k10 Gene Contains Three
Functional C/EBP Binding SitesTo determine whether C/EBPs might be involved in the
upregulation of k10 expression during keratinocyte differ-









168 Maytin et al.entiation, a k10 promoter fragment was isolated for use in
inding and transactivation studies in BALB/MK cells, an
mmortalized keratinocyte line (Weissman and Aaronson,
983) that reproduces many of the differentiation-related
hanges that occur in the epidermis, including the sequen-
ial upregulation of C/EBPb and C/EBPa (Maytin and Ha-
bener, 1998). The BALB/MK cells, exposed to high-calcium
(differentiation-promoting) medium, respond with an in-
crease in K10 expression within 24 h, measurable at the
protein (Fig. 2A) and mRNA (Fig. 2B) levels. These results
agree with earlier findings in which K10 increases in
primary murine keratinocytes at 1–2 days of differentiation
(Yuspa et al., 1989).
FIG. 1. Spatial relationships of C/EBPs, AP-2, and K10 in the strat
old) were immunostained as described under Materials and Metho
layers of the epidermis are shown in the line drawing (upper lef
epidermis and dermis is indicated by dashed lines, between living ep
basal and suprabasal epidermal layers by horizontal arrowheads.
recombinant C/EBPa or C/EBPb expressed in cos cells, recombinan
differentiating mouse keratinocytes are seen as bands of the corre
antibody. (C) K10 in the suprabasal layers. (D) C/EBPa, abundant in
basal layer and highly abundant in the suprabasal layers. (E9) The
ntibody. Arrows in E and E9 are for orientation. ns, nonspecific sta
/EBPb (F), and for K10 (F9), with the two images superimposed bThe cloned segment of the 59 flanking region of mouse
k10 revealed several features (Fig. 3A). Nucleotide similari-
Copyright © 1999 by Academic Press. All rightties were found with the human (Rieger and Franke, 1988)
and bovine (Rieger et al., 1985) k10 promoters. An identity
of 95–100% nucleotides is present in the first 170 bp, a
sequence containing three C/EBP binding sites (designated
A, B, and C). All three sites (Site B oriented in the reverse
direction) closely resemble the consensus binding motif for
C/EBPs (Fig. 3A, bottom). To determine whether these sites
bind C/EBPs, DNase I protection analyses of the k10
promoter were performed (Fig. 3B). Recombinant C/EBPb
protected a region extending from 2140 to 2176 bp (Fig.
3B). A hypersensitive region was found within this foot-
print, between Sites A and B (Fig. 3B, asterisk). Site C
corresponded to a location that showed weak protection
epidermis. Frozen sections from the skin of newborn mice (5 days
elative locations of the basal (B), suprabasal (SB), and cornified (C)
in (A), a phase-contrast image. In A–F0, the boundary between
al layers and the dead cornified layer by dotted lines, and between
ificities of the antibodies used are indicated on the left, where
-2a expressed in reticulocyte lysates, and native K10 expressed in
ze on Western blots. (B) AP-2 in the basal layer, using the sc-184
highest suprabasal layers. (E) C/EBPb, moderately expressed in the
e field shown in E, but now stained for AP-2a, using the sc-6312
in the cornified layers. (F–F0) A single specimen double stained for







thefrom DNase I, but was flanked by two strong hypersensitive
sites consistent with a possible C/EBPb-induced conforma-






















169C/EBP and AP-2 Transcription Factor Network in Skintional change in the DNA (Fig. 3B, upper two asterisks). The
individual DNA sequence motifs were tested in gel-shift
assays for their ability to bind C/EBPs (Fig. 3C). 32P-labeled
oligonucleotides, corresponding to each of the three motifs,
bound recombinant C/EBPb in a C/EBP-specific manner, as
demonstrated via competition with a high-affinity C/EBP-
binding oligonucleotide and via supershift studies with
antisera against C/EBPb (Fig. 3C). Oligonucleotides with
mutations in each of the sites (Mut A, Mut B, or Mut C)
failed to compete for C/EBPb binding and failed to bind
C/EBPb when used as probes (Fig. 3C). The affinity of
binding to C/EBPb differed for each of the sites, with the
affinity at Site A being 5- to 10-fold higher than for sites B
and C, based upon differential film exposure times (data not
shown). However, the affinities of the sites measured in
isolation (Fig. 3C) do not address the issue of cooperative
FIG. 2. Expression of the k10 gene is increased in a
differentiation-associated manner in calcium-induced keratino-
cytes. Confluent cultures of BALB/MK cells were switched to
high-calcium medium for the times indicated and harvested for
total cellular proteins and for RNA. (A) Western immunoblot
analysis of BALB/MK proteins, using an antibody to keratin K10;
molecular size (kilodaltons) shown at left. (B) Analysis of K10
mRNA expression; molecular sizes (kilobases) shown at left. (Top)
RT-PCR using primers to a region at the 39 end of the K10 mRNA;
ethidium-stained agarose gels are shown. (Bottom) Southern blots
from the same gels, probed with a 32P-labeled K10 probe. Controls,
CRs were run with a plasmid containing a K10 cDNA insert
pK10) and with cDNA prepared from mouse epidermal RNA
skin). (C) RT-PCR products from the same RNA samples used in
B), using primers specific for mouse actin. pActin, a control from
CR amplification of a plasmid containing mouse actin sequences.binding effects, observed when the sites lie adjacent to one
another in native k10 DNA (see below).
Copyright © 1999 by Academic Press. All rightC/EBPb Is Present in Keratinocyte Nuclear
xtracts and Binds to the k10 Promoter
n a Differentiation-Specific Manner
To show that C/EBPs are present within nuclei and bind
to the k10 promoter in a differentiation-specific manner,
proteins were extracted from the nuclei of BALB/MK cells
at various times during calcium-induced differentiation and
analyzed for C/EBP-binding activity via gel-shift analysis.
Nuclear extracts were mixed with a 44-bp probe containing
Sites A and B from the k10 promoter. Two specific com-
lexes which increased in intensity over the first 3 days of
ifferentiation, and then decreased by 7 days, were observed
Fig. 3D). The composition of these complexes was exam-
ned via immunosupershift and oligonucleotide competi-
ion experiments (Fig. 3D). Specific complexes were dis-
upted by antisera against C/EBPb (lane 6), but not by
antisera to C/EBPa nor CHOP. DNA competition with the
M6 oligonucleotide, a high-affinity C/EBP-binding site
(Brasier et al., 1990), selectively abolished the specific
complexes (lanes 9 and 10), whereas competition with the
unlabeled k10 probe itself competed both the specific and
the nonspecific complexes (lanes 11 and 12). These results
implicate C/EBPb as a predominant factor responsible for
differentiation-dependent binding activity at the C/EBP-
binding sites within the k10 promoter during the differen-
tiation of BALB/MK cells.
C/EBPb Introduced into Keratinocytes Activates
he k10 Promoter through a Mechanism That Is
/EBP-Specific and DNA Binding Site-Specific
To test whether C/EBPs can regulate k10 transcription in
ivo, a reporter plasmid containing the 245-bp wild-type
10 promoter fused to the luciferase reporter gene
pWtK10Luc) was cotransfected into BALB/MK cells with
xpression plasmids for C/EBPa, C/EBPb, or CHOP (Fig. 4).
Expression of both C/EBPa and C/EBPb activated
WtK10Luc by 6- to 12-fold relative to the empty expres-
ion vector, pCDNA (Fig. 4A). C/EBPa was more effective
than C/EBPb in activating the k10 reporter. CHOP, as
expected from its inability to bind DNA (Ron and Habener,
1992), failed to activate the k10 reporter. The empty lucif-
erase reporter vector alone, pOLuc, was not affected by any
of the expression constructs, confirming that transactiva-
tion effects observed were attributable to k10 promoter
sequences.
Additional transfection/transactivation experiments were
performed to test the specificity of interactions between k10
and C/EBP. Cotransfection of full-length 32-kDa C/EBPb
(LAP) and pWtK10Luc resulted in transactivation of the k10
promoter (Fig. 5B, left side). A fivefold excess of the 20-kDa
inhibitory form of C/EBPb (LIP), introduced into the cells
along with LAP, attenuated the transactivation of k10. Simi-
larly, overexpression of the dominant-negative inhibitor,
CHOP, also inhibited transactivation. These effects depended
on the presence of intact C/EBP-recognition sites in DNA,
because a k10 promoter construct (pMutABC) containing
s of reproduction in any form reserved.
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172 Maytin et al.point mutations at Sites A, B, and C failed to respond to
C/EBPb, either in the presence or in the absence of excess
inhibitory proteins (Fig. 5B, right).
Full Activation of the k10 Promoter by C/EBPb
Requires Three Intact C/EBP-Binding Sites
within the Promoter
The role of each C/EBP-binding site in the k10 promoter
was examined by creating point mutations within Sites A,
B, and C (Figs. 4C–4E). Each mutation abolished binding of
C/EBPb at the individual sites; see Fig. 3C. Mutations were
introduced into the k10 promoter either individually or
together in all combinations, to yield a panel of mutant k10
transcriptional reporters (Fig. 4C). These reporters were
tested in cotransfection experiments with a C/EBPb expres-
sion vector (Fig. 4D). The effects of these mutations upon
transcriptional activity proved to be complex, with loss of
any one of the sites leading to derepression of basal tran-
scription and a concomitant loss in relative C/EBP regulat-
ability. The latter point is best seen in Fig. 4E, in which the
mutants are displayed in decreasing order of ability to
respond to C/EBPb. Thus, in comparison to the fourfold
induction of the wild-type k10-luciferase reporter after
C/EBPb, mutation of Site A alone caused only a 50%
FIG. 3. The mouse k10 promoter contains three C/EBP binding
eratinocyte nuclear extracts. (A) Comparison of the murine k10 p
ovine k10 genes; locations of C/EBP-binding motifs. Nucleotides
ATA-binding site, the transcription initiation site (TRX) and the
andidate sites for binding of C/EBPs, are delineated by boxes and a
inding (Osada et al., 1996). The sequence labeled “mK10 in 1985”
(Krieg et al., 1985); bases that differ from our sequence are shown,
analysis of the K10 promoter. A 245-bp fragment of the murine k1
increasing amounts (0, 50, 100, 200, 400, and 800 ng) of a recombina
el and exposed to film. Footprinted regions (vertical arrows, on
boxes). Hypersensitive sites are indicated by asterisks. Nucleotide
left. (C) Gel-shift analyses demonstrating the affinity and specificit
a recombinant C/EBPb. In the three gels on the right, three differ
promoter sequence (wildtype Site A, B, or C; see A and Materials a
C (mA, mB, or mC; also see Fig. 4C and Materials and Methods) we
alone. In the gel on the left, a standard high-affinity C/EBP-binding
et al., 1990) served as the probe. Locations of DNA–protein comple
lanes indicate the following successive additions (also see labeling a
f unlabeled C/EBPb standard (S) oligonucleotide, (4) 100-fold exce
mutant oligonucleotide (mA, mB, or mC), (6) antibody against C/E
utant probe (mA, mB, or mC) to demonstrate absence of binding a
days for the Site B and Site C probes. (D) Characterization of native
uclear extracts, 1 ml, from cells exposed to 0.12 mM calcium for 0
robe) containing Sites A and B from the K10 promoter (see Ma
onspecific complex (NS) were observed. In the subsequent exper
analysis with antisera: Addition of either 1 ml of anti-C/EBPa
nti-C/EBPb antisera (lane 6) perturbed the specific complexes and
Addition of a 10-fold (lane 9) or 100-fold (lane 10) excess of unlabele
C/EBP-containing complexes. The K10 probe itself (K10, lanes 11 a
expected. Supershift (SS) controls: Positive controls to show that the an
13 and 14) or C/EBPb (lanes 15 and 16). The M6 probe (Standard) was d
Copyright © 1999 by Academic Press. All righteduction in C/EBPb-stimulated activity of the k10 pro-
oter. Elimination of either Site B or Site C caused smaller
eductions in k10 activity. Double mutants confirmed the
elative importance of Site A; constructs with a mutation in
and A or C and A, but not B and C, showed significant
ecreases in k10 activation by C/EBPb. Importantly, how-
ever, only the triple mutation (Mut ABC) showed 100% loss
of C/EBPb-inducibility. Therefore, despite the higher affin-
ity of Site A relative to Sites B or C when tested in isolation
(Fig. 3C), all three sites appear to be important in the native
promoter, i.e., all must be intact to achieve full activation
of the k10 promoter in response to C/EBPb.
Targeted Disruption of the c/ebpb Gene Results
n Ectopic Increases in Expression of C/EBPa
and K10 in the Basal Layer of the Epidermis
Having established a role for C/EBPb in the regulation of
he k10 promoter in vitro, we investigated its role in the
skin in vivo. A targeted disruption of the c/ebpb gene in
mice, which led to the development of lymphocyte abnor-
malities in aged mice, was described previously; no pheno-
typic changes were reported in the skin (Screpanti et al.,
1995). When these mice were backcrossed into a FVB/n
background, a skin phenotype appeared (Fig. 5). The c/ebpb
tifs which specifically bind C/EBPs, including C/EBPb found in
al promoter region with the corresponding regions of human and
served between at least two of the three species are shaded. The
slation start site (TRL) are boxed. Sites A, B, and C, representing
o shown at the lower right beneath the consensus motif for C/EBP
otes the 59 end of the published sequence of the murine k10 gene
e identical bases are indicated by asterisks. (B) DNase I protection
moter was labeled with 32P at the 59 terminus and incubated with
-kDa isoform (LIP) of C/EBPb and then separated on an acrylamide
) encompass the C/EBPb-binding sites predicted from A (vertical
ions, derived from the sequencing lane (G-ladder), are given on the
inding for each of three sites (A, B, and C) in the K10 promoter to
2P-labeled 26-bp oligonucleotides derived from the wild-type k10
ethods) or 26-bp oligonucleotides with mutations at sites A, B, or
ubated with 1 ml of a gst-C/EBPb bacterial lysate or with the probe
(Standard; the M6 mutant from the angiotensinogen gene) (Brasier
C/EBPb1DNA) and free probe are indicated. In all gels, numbered
the gels): (1) probe alone, (2) gst-C/EBPb protein, (3) 100-fold excess
unlabeled probe itself (A, B, or C), (5) 100-fold excess of unlabeled
. In lane (7), gst-C/EBPb protein was incubated with a 32P-labeled
mutated sites. Film exposure time was 40 h for the Site A probes,
BP-binding activity in differentiating BALB/MK cells. Time course:
r 7 days were mixed with a radiolabeled 40-bp oligonucleotide (K10
ls and Methods). Changes in two specific complexes (SC) and a
ts, 1 ml of 3-day nuclear extract was used in all lanes. Supershift
era (lane 5), or anti-CHOP antisera (lane 7), had no effect, but
ed supershifted complexes instead. Oligonucleotide competition:
ndard oligonucleotide (M6) eliminated binding only of the specific




























nd 1tisera are capable of supershifting recombinant gst-C/EBPa (lanes
escribed in C.















173C/EBP and AP-2 Transcription Factor Network in Skinnull mice were slightly smaller than controls and mani-
fested a scruffy appearance of their coats (Fig. 5, top left).
The phenotypic changes in the fur allowed identification of
homozygous animals before confirmation by genotyping.
The histomorphology of hematoxylin- and eosin-stained
skin in the c/ebpb null-mice appeared similar to that of
FIG. 4. A k10 promoter–luciferase reporter can be transactivated b
motifs in the DNA. (A) Expression constructs (0.5 mg) containing th
CDNA vector (2), were cotransfected into BALB/MK cells along
promoter (pWtK10Luc) or reporter vector alone (pOLuc). Cells wer
luciferase activity (arbitrary units). Induction ratios, relative to em
mean 6 SEM for three experiments, each done in triplicate and
(pWtK10Luc) or a mutant reporter in which all three C/EBP-cons
vectors encoding full-length C/EBPb (LAP), truncated C/EBPb (LIP)
significant K10 promoter activity, but when C/EBPb was cotran
C/EBPb-induced activation was abolished. All values are from the
riplicate. (C) Nomenclature (left side) and arrangement of mutated
10 construct was 245 bp in length, with mutations in the k10 pro
ethods for sequence. (D) Transactivation of wild-type or mutant k
onstructs (5 mg) were cotransfected into BALB/MK cells together w
alone (open bars), and harvested at 48 h for luciferase assay. Raw d
triplicate. Error bars represent the means 6 SEM. For each K10 mu
above the bar. (E) Induction ratios for the wild-type and mutant k10–
to C/EBPb. Error bars represent means 6 SEM. Asterisks, signific
Student t test (*P , 0.01; **P , 0.001).ontrols; no obvious changes in the epidermis and dermis,
or in the size and number of hair follicles, were seen (Figs.
Copyright © 1999 by Academic Press. All rightA and 5A9). However, substantial (;50%) thinning of the
ubcutaneous fat layer was observed (see Fig. 5A9 and figure
egend), consistent with the decreases in interscapular and
pididymal adipose tissue previously reported in c/ebpb
null mice (Tanaka et al., 1995).
Closer examination of skin sections using a panel of
ferent C/EBP isoforms, in a manner requiring three C/EBP-binding
tein-coding sequences for C/EBPa, C/EBPb, or CHOP, or the empty
5 mg of a luciferase reporter containing either the wild-type K10
rvested at 48 h for luciferase assay. Data are expressed as relative
pCDNA, are shown above some of the bars. Values represent the
alized to the empty-vector controls. (B) The wild-type reporter
s sites have been altered (pMutABCLuc) was cotransfected with
HOP (Chop) or with pCDNA alone (2). By itself, C/EBPb induced
ed with a five-fold excess (2.5 mg) of either LIP or CHOP, the
e experiment. Each bar represents the mean 6 SD, for dishes in
(boxes), for the k10–luciferase reporters used in these studies. Each
r introduced at Sites A, B, and/or C as indicated; see Materials and
ciferase constructs; pOLuc, empty SKLuc reporter vector. Reporter
0.5 mg full-length C/EBPb in pCDNA (solid bars), or with pCDNA
ere pooled from three experiments, each condition in duplicate or
the relative ratio (fold increase) due to addition of C/EBPb is given
erase constructs, displayed in order of decreasing ability to respond














ata wantisera directed against transcription factors and keratins
revealed major differences between c/ebpb null and control












174 Maytin et al.mice (Fig. 5). C/EBPb protein was absent in the epidermis of
c/ebpb null mice (Figs. 5B and 5B9). Although CHOP
expression remained unchanged (Figs. 5C and 5C9), a
marked increase in the distribution of C/EBPa expression
as observed within the epidermal layers (Figs. 5D and
D9). Compared to the normal pattern of C/EBPa expression
(in the high suprabasal layers), C/EBPa in c/ebpb null mice
FIG. 5. Gross appearance, standard histology, and immunohistoc
skin of c/ebpb null mice. (Top) Photograph of a pair of littermate
(2/2, right) for the targeted deletion in the c/ebpb gene. A “scruff
H&E stains of dorsal skin from a c/ebpb 1/2 and a c/ebpb null a
easured digitally, from the skin of 5 heterozygous versus 5 nulli
9.4 6 1.6 mm); d, dermis (315 6 34 mm vs 291 6 24 mm); a, adipo
adipose layer was significantly thinner in the c/ebpb 2/2 mice, St
from pairs of mice (left, c/ebpb 1/2, right, c/ebpb 2/2), mounted on
ntiserum indicated. Photographic exposure times were identical fo
ines, junction between living epidermis and stratum corneum. Hoxtended downward to include all of the cells in the
uprabasal and basal layers. C/EBPa expression was in-
Copyright © 1999 by Academic Press. All rightreased in both concentration (fluorescent intensity) and
eographic area (Fig. 5D9). These changes in expression of
/EBPa were significant when the skins of multiple ani-
mals were studied by computer-assisted image analysis
(Table 1). Notably, in the epidermis of c/ebpb null mice, the
expression of K10 was also markedly increased (Figs. 5E and
5E9). The normal suprabasal pattern of K10 now expanded
ical analysis of transcription factor and keratin expression in the
eeks old, both females), heterozygous (1/2, left) or homozygous
pearance of the coat is evident in the c/ebpb 2/2 mouse. (A, A9),
l, respectively. The thickness of each of the indicated layers was
s mice, as follows (mean 6 SEM): e, epidermis (18.2 6 1.4 mm vs
er (170 6 24 mm vs 95 6 13 mm); m, muscle (not measured). The
t t test, P , 0.0005. Scale bar, 100 mm. (B–G) Frozen skin sections
same slide and analyzed by immunofluorescence using the specific
h pair of images. Dashed lines, dermal–epidermal junction. Dotted







thedownward into the basal layer (Fig. 5E9). Upregulation of
K10 appeared to be specific, because the expression levels of
































175C/EBP and AP-2 Transcription Factor Network in Skinanother epidermal keratin, K14, remained unchanged (Figs.
5F and 5F9).
AP-2 Resides in a Pathway between C/EBPb
and C/EBPa, Linking the Increase of C/EBPa
to the Loss of C/EBPb in the Epidermis
of c/ebpb Null Mice
As an explanation for the increase in C/EBPa expression
in c/ebpb null skin (e.g., active stimulation versus removal
f repression), we considered repression of c/ebpa gene
xpression by AP-2. Such an explanation would have to
nclude a role for C/EBPb in the maintenance of AP-2
expression, in order to explain derepression of C/EBPa in
he skin of c/ebpb null mice. Two experiments were
performed, the results of which support such a role. First,
immunostaining demonstrated a near complete disappear-
ance of AP-2 in the epidermis of c/ebpb null mice, consis-
ent with the notion that C/EBPb is essential for AP-2
xpression (Figs. 5G and 5G9). Second, an examination of
egulatory sequences upstream of the AP-2a gene (Meier et
l., 1995) revealed several potential C/EBP-binding site
otifs. Two of these motifs, located at nucleotide positions
15 and 365 (GenBank Accession No. U17289), were tested
or their activity as C/EBPb-responsive enhancers of tran-
cription. An 87-bp sequence of the AP-2 promoter contain-
ng these two motifs was linked to a transcriptional reporter
omprising the K10 minimal promoter fused to the lucif-
rase gene (see Materials and Methods). When cotransfected
nto keratinocytes in the absence or presence of an expres-
TABLE 1
Integrated Fluorescence Intensitiesa of Epidermal Transcription Fa





1 10 F 1/2 527 6
11 F 2/2 539 6
2 12 M 1/2 536 6
14 M 2/2 507 6 1
3 15 F 1/2 477 6
17 F 2/2 566 6 1
4 19 M 1/2 502 6
20 M 2/2 457 6 1
a Histologic specimens (5-mm frozen sections) from the skin o
were immunostained with primary antisera to the proteins indica
intensity was analyzed as described under Materials and Method
ntegrated fluorescence intensity per unit length of epidermis. Unit
hickness can vary considerably. Statistical comparison by the Stu
b No values are listed for C/EBPb because quantitation was n
C/EBPb-specific signals in controls versus the complete absence o
* P , 0.01.
** P , 0.005.
*** P , 0.0005.ion plasmid for C/EBPb, the AP-2 promoter was activated
in a C/EBP-dependent manner (Fig. 6). Disruption of the
Copyright © 1999 by Academic Press. All rightinding motifs by selective mutation completely abolished
/EBPb-inducibility of the AP-2 promoter (Fig. 6).
ap-2a Nullizygous Mice Reproduce the Skin
henotype of c/ebpb Null Mice, with Increased
Epidermal C/EBPa and K10
To determine whether c/ebpb and ap-2a may lie in a
pathway upstream of c/ebpa and k10, epidermis from mice
acking the ap-2a gene was examined (Schorle et al., 1996).
xperiments were limited to late-stage fetal skin, since
p-2a null mice die perinatally with severe cranial and
bdominal wall defects (Schorle et al., 1996). However,
hese mice develop intact skin over the upper thoracic
egion (Zhang et al., 1996). Frozen sections from 17.5- to
8.5-day embryos were tested using the panel of antisera
hown in Fig. 7. As with c/ebpb null mice, the ap-2a null
ice showed an overall increase in C/EBPa staining inten-
sity (Figs. 7B and 7B9 and Table 2) and a marked increase in
C/EBPa expressed ectopically in basal cell nuclei (Figs. 7C
and 7C9). K10 expression was increased in the suprabasal
layers (Figs. 7E and 7E9 and Table 2), although no expansion
into the basal layer was noted in this case. No changes were
seen in the hair follicles. The levels of expression of C/EBPb
(Figs. 7D and 7D9), K14 (Figs. 7F and 7F9), and CHOP (data
not shown) were unchanged.
DISCUSSION
An important goal in epidermal biology is to identify
b and Keratins in the Skin of Adult c/ebpb Knockout Mice
C/EBPa K14 K10
Mean 6 SD Mean 6 SD Mean 6 SD
343 6 88 4551 6 810 3462 6 414
574 6 78** 4278 6 1433 8521 6 976***
322 6 31 2976 6 548 2668 6 491
705 6 82** 3167 6 479 3785 6 547**
311 6 107 3023 6 287 3531 6 380
603 6 60** 3153 6 208 4691 6 711**
347 6 72 2091 6 402 2476 6 1194
618 6 135** 2006 6 474 4718 6 796**
red littermates, laid adjacent to one another on microscope slides,
followed by Cy3-conjugated secondary antisera, and fluorescence
lues shown represent the means 6 SD (n 5 6 fields/animal) of
h was used for normalization rather than unit area, since epidermal
t test (P value) is shown for each pair of animals.
equired to demonstrate the all-or-none difference between strong

















f signdifferentiation-specific transcription factors that determine
the expression of tissue-specific target genes during kera-

































176 Maytin et al.tinocyte differentiation (reviewed in Fuchs, 1993). Here we
show that C/EBP and AP-2 transcription factors together
regulate the transcriptional activity of the keratin k10 gene
n the epidermis. C/EBPs act directly upon the k10 pro-
oter. Although C/EBPa and C/EBPb can both activate the
k10 gene, they are differentially expressed in the stratified
epidermis. C/EBPb acts early and C/EBPa acts later during
pward migration and differentiation of keratinocytes.
P-2 influences k10 transcription indirectly as a repressor
f C/EBPa expression in the basal layer of the epidermis,
where C/EBPb and AP-2 are both expressed. In the high
suprabasal layers, AP-2 expression is extinguished and
C/EBPb expression is superceded by expression of C/EBPa.
A novel aspect of the findings is that c/ebpa, c/ebpb, and
p-2a genes are functionally linked in a regulatory network
hat ultimately determines the expression of the k10 gene
n the skin in vivo.
C/EBPs Directly Regulate k10 Gene Transcription
FIG. 6. C/EBPb-responsive enhancer elements are found in the
upstream regulatory region (exon 1a) of the ap-2a gene. Luciferase
reporter constructs were constructed by placing an 87-bp region of
the ap-2a promoter containing two putative C/EBP-enhancers at
2710 and 2760 bp (pWtAP2Luc) in front of the luciferase gene
driven by a minimal promoter (LUC); see Materials and Methods.
In a mutant version of the construct, both AP-2 enhancers were
disrupted by site-directed mutagenesis (pMutAP2Luc; mutant
bases in lowercase italic). Each of these constructs, or the empty
reporter (pOLuc), was cotransfected with C/EBPb-expression plas-
mid (hatched bars) or empty pCDNA (open bars) into BALB/MK
cells, and the cells were harvested at 48 h for luciferase assay. Data
were pooled from three experiments, each performed in triplicate,
and normalized using the baseline (empty vector) values; error bars
represents the means 6 SEM.Although the suprabasal expression pattern of keratin
k10 in the epidermis has been well characterized (Roop et
m
t
Copyright © 1999 by Academic Press. All rightl., 1988; Yuspa et al., 1989), the regulation of the k10
romoter has not been examined in detail. We identified a
luster of three C/EBP-binding sites within the proximal
10 promoter via footprint and gel-shift analysis. All three
ites were shown by site-directed mutagenesis studies to be
ssential for C/EBP responsiveness of the k10 promoter
Figs. 3 and 4). The presence of these sites appears to
aintain the k10 promoter in a relatively suppressed state
t baseline, since mutation of any one of the three sites
ncreases basal promoter activity in keratinocytes (Fig. 4D).
hether this reflects a physical interaction between the
ites through bending of the chromatin (e.g., hairpin forma-
ion in the presence of C/EBPs and/or other binding pro-
eins), as shown for the case of multiple CREB-responsive
lements (Spiro et al., 1995), is an interesting hypothesis for
uture study. For purposes here, characterization of the
/EBP-responsive sites was essential to confirm that the
10 promoter can be regulated by C/EBPs at the transcrip-
ional level.
Multiple C/EBP-responsive motifs have been demon-
trated experimentally in only a few other genes to date,
ncluding keratin K6 (Blumenberg et al., 1998) and a-1 acid
lycoprotein (Lee et al., 1993). For the k10 promoter, such
redundancy may preserve transcriptional expression of this
vital intermediate filament gene. The disease epidermolytic
hyperkeratosis illustrates the importance of proper k10
expression in cutaneous biology. K10 normally assembles
into cytoskeletal filaments as a heterodimer with its spe-
cific partner, keratin K1; together, K1 and K10 constitute
;85% of the protein in fully differentiated keratinocytes
(Cheng et al., 1992). Perturbation of K1:K10 filaments via
dominant-negative mutations in K10, either introduced
experimentally into transgenic mice (Fuchs et al., 1992) or
naturally occurring in the heritable disease epidermolytic
hyperkeratosis (Cheng et al., 1992; Rothnagel et al., 1992;
Syder et al., 1994), leads to epidermal cytolysis and blister-
ing, with severe clinical consequences.
AP-2 Acts Indirectly upon k10 Expression
via Activation or Repression of the c/ebpa,
c/ebpb, and ap-2a Gene Promoters
To determine how C/EBPa and C/EBPb regulate k10
expression in the skin in vivo, we examined the skin of
mice lacking c/ebpb. In the c/ebpb null animals, the k10
phenotype of increased expression was initially difficult to
explain. However, it was noted that C/EBPa transactivates
the k10 promoter (Fig. 4A). In the c/ebpb null mice, loss of
/EBPb is compensated for by an increase in epidermal
C/EBPa. It is reasonable to propose that C/EBPa activates
ranscription of the k10 gene in c/ebpb null mice because
C/EBPa and K10 are both expressed ectopically in cells of
the basal layer, a place where neither gene is normally
expressed.
Why is C/EBPa upregulated in the skin of c/ebpb null
ice? Among several possible mechanisms, a release from
ranscriptional repression was considered. Analogous to the














e l arrows, top of the basal layer. Magnification: The white bar in A9 (scale







177C/EBP and AP-2 Transcription Factor Network in Skinrole of AP-2 as a repressor of the c/ebpa promoter in mitotic
preadipocytes (Jiang et al., 1998), we hypothesized that
AP-2 may be a repressor of C/EBPa in the basal epidermis.
his hypothesis is supported by our findings that in the
kin of ap-2 null animals, expression of C/EBPa is increased
(Fig. 7). Also, because AP-2 expression is lost in the epider-
mis of c/ebpb null mice, loss of AP-2-mediated repression
can explain the high C/EBPa levels seen in those animals
(Fig. 5). Why is AP-2 expression lost in c/ebpb null mice? At
east part of the mechanism may be transcriptional, since
e have shown that the ap-2a gene promoter contains at
east two C/EBP-responsive enhancer elements (Fig. 6).
ollectively, the above observations suggest a model in
hich c/ebpb, ap-2a, and c/ebpa genes are linked in a
egulatory network (Fig. 8). Within a given cell (e.g., a
eratinocyte in the basal layer), C/EBPb activates or main-
tains transcription of the ap-2a promoter (Fig. 8A). AP-2, in
urn, represses C/EBPa expression. In c/ebpb null mice (Fig.
B), the elimination of AP-2 expression unmasks a C/EBP-
inding site in the C/EBPa promoter (Tang et al., 1997),
llowing positive autoregulation of C/EBPa and subsequent
FIG. 7. Analysis of transcription factors and epidermal keratins in
(ap-2a 1/1) or nullizygous (ap-2a 2/2) mice, analyzed by imm
pidermal junction. Dotted lines, top of living epidermis. Horizonta
ar, 20 mm) applies to all images except C and C9, for which the sthe skin of ap-2a null mice. Frozen sections from the skin of wild-type
unofluorescence using the antisera indicated. Dashed lines, dermal–upregulation of k10. Elimination of ap-2a by gene targeting
yields a skin phenotype similar to that in Fig. 8B, with the
Copyright © 1999 by Academic Press. All rightTABLE 2
Integrated Fluorescence Intensitiesa of Epidermal C/EBPa and





Mean 6 SD Mean 6 SD
1 a3 1/2 2519 6 350 2683 6 121
a2 2/2 3652 6 419** 3470 6 189*
2 a17 1/1 2485 6 246 2826 6 137
a16 2/2 3151 6 242** 3846 6 192**
3 a22 1/2 2314 6 163 2774 6 193
a20 2/2 3178 6 232** 4276 6 267**
4 a25 1/2 2598 6 171 2351 6 287
a23 2/2 3764 6 463* 4053 6 231**
a Paired histologic specimens were immunostained with primary
antisera to either C/EBPa or K10, followed by secondary antisera
onjugated to Cy3, and were then quantitated by digital image
rocessing as described under Materials and Methods and the legend
o Table 1. Values (means 6 SD, n 5 6 microscopic fields/animal) repre-
ent integrated fluorescence intensity per unit length of epidermis.
he Student t test results (P values) are shown for each pair of animals.* P , 0.001.
** P , 0.0005.





















178 Maytin et al.exception that C/EBPb remains unaltered, since it lies
upstream of ap-2a.
The geographic distribution of C/EBPa, C/EBPb, and
AP-2 within the various epidermal layers plays a role in k10
expression in vivo, as summarized in Fig. 8C. Normally,
C/EBPb is present in low amounts in the basal cells, then
undergoes a surge of expression as the cells enter the
suprabasal layers. C/EBPa is normally repressed in the basal
ayers by the presence of AP-2. Once AP-2 expression is
ost, in either the c/ebpb or the ap-2a knockout models,
C/EBPa expression is activated in the lower epidermis, with
ualitative increases in the basal layer (Figs. 7C and 7C9)
nd quantitative increases in the low suprabasal layers
Tables 1 and 2). Increased C/EBPa expression leads to
ugmented k10 expression at the locations noted (Fig. 8C).
While we have shown that either C/EBPa or C/EBPb can
ontribute to k10 expression (Fig. 4A), C/EBPs are clearly
ot the only factors involved. For example, k10 expression
is normally off in the basal layer, even in the presence of
low amounts of C/EBPb. Therefore, additional unknown
FIG. 8. Model for regulatory interactions between C/EBPs and A
gene-promoter level, in either (A) wild-type or (B) cebpb null mice
amily (hatched boxes), or unidentified factors (gray boxes) are sh
actors and the k10 target gene, at different cell layers in the epideactors (designated “Z” in Fig. 8) must play a role in the
ctivation of k10 at the basal/suprabasal transition. m
Copyright © 1999 by Academic Press. All rightPotential for Additional Regulatory Interactions
Our data raise several additional questions. For example,
why does the expression of keratin K14 remain unaltered in
the ap-2a null and the c/ebpb null mice, despite reports
hat AP-2 is intimately involved in k14 transcription (Byrne
t al., 1994; Leask et al., 1991)? It is possible that multiple
AP-2 family genes are expressed in the skin. Epidermal
expression of AP-2b (Moser et al., 1997) and of AP-2g
(Buehner et al., 1998; Oulad-Abdelghani et al., 1996) has
been reported in mouse skin at the mRNA level. In our
work, expression of several AP-2 family proteins in murine
epidermis is suggested by the persistence of faint immuno-
staining of the basal layer of the epidermis in ap-2a null
ice using the sc-184 antibody from Santa Cruz, Inc. (data
ot shown). The sc-184 antibody is not specific for AP-2a,
ince it also detects AP-2b and AP-2g (albeit to a lesser
xtent) when tested against in vitro-translated proteins on
estern blots; see Materials and Methods. Thus, in mice
acking AP-2a, the presence of AP-2b and AP-2g may be
sufficient to maintain k14 gene expression. In contrast,
actors in the epidermis. (A and B) Network of interactions at the
nsensus elements for binding of C/EBP-family (solid boxes), AP-2
. (C) Spatial features of the cross-regulation among transcription
. B, basal layer. SB, suprabasal layer. See text for details.P-2 f
. CoAP-2b and AP-2g (assuming they are present) appear to be
uch less effective than AP-2a in repressing the c/ebpa















179C/EBP and AP-2 Transcription Factor Network in Skingene, since C/EBPa is strongly upregulated in the epidermis
f ap-2a null mice.
Another question is the possible involvement of alterna-
tive isoforms of c/ebpa, c/ebpb, and ap-2a in the regulation
f k10. For example, LIP (a C/EBPb isoform) or the 30-kDa
soform of C/EBPa might counteract stimulatory effects of
activator C/EBP isoforms. We have demonstrated that the
long and short protein isoforms of both C/EBPa and C/EBPb
are expressed in the epidermis (Maytin and Habener, 1998).
A major role for these short isoforms seems unlikely,
however, because the amount of the short isoforms relative
to the full-length proteins is small (,20%) and because no
significant changes in the ratios of LIP to full-length
C/EBPb or of C/EBPa–30 kDa to full-length C/EBPa were
observed (data not shown). Likewise, no major changes in
levels of CHOP were observed in this study. However,
because CHOP (a dominant-negative repressor of C/EBPs) is
expressed in the epidermis along a gradient similar to that
of C/EBPb (Maytin and Habener, 1998), we cannot exclude
a counterregulatory role for CHOP that might be demon-
strable in a different experimental context. In the case of
AP-2, a role for multiple isoforms must also be considered.
Four AP-2 isoforms, produced by alternative RNA splicing,
are expressed in murine skin (Meier et al., 1995). In particu-
lar, a splicing variant which can form heterodimers but
lacks the N-terminal transactivation domain could func-
tion as a dominant-negative inhibitor (Meier et al., 1995).
The large number of isoforms, each with a potential to
participate in autoregulation and cross-regulation among
the C/EBP-family and AP-2 family genes, adds to the
potential complexity of k10 regulation.
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